newsfilter
← Latest News
Business Wire·

Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for the 2026-2027 Academic Year

  • Sarepta Therapeutics announced 25 recipients of the Route 79, The Duchenne Scholarship Program for the 2026-2027 academic year.
  • The awards include 20 scholarships for individuals living with Duchenne & 5 scholarships for their siblings.
  • This marks the ninth year of the program, which has awarded over 150 scholarships in total.
  • Each recipient receives a scholarship of up to $5,000.
  • Selection is handled by an independent committee of Duchenne community members evaluating academic records, community involvement, essays, & recommendation letters.
  • Submissions are de-identified to ensure no bias regarding Sarepta therapy status.
  • The program name "Route 79" references the 79 exons of the dystrophin gene, which is associated with Duchenne muscular dystrophy.
  • Recipients are pursuing diverse post-secondary degrees at institutions including Southern Methodist University, University of Colorado Boulder, & San Jose State University.